EFFECT OF SIZE AND DOSAGE STRENGTH ON THE BIOVAILABILITY OF 2 DILTIAZEM FORMULATIONS DURING REPEATED ADMINISTRATIONS IN HUMANS

被引:2
作者
CAMPISTRON, G
ROSTIN, M
COULAIS, Y
CAILLARD, C
ZARROUK, G
FRANCES, J
THIERCELLIN, JF
MONTASTRUC, JL
HOUIN, G
机构
[1] CHU PURPAN,UNITE PHARMACOCINET CLIN,F-31059 TOULOUSE,FRANCE
[2] FAC SCI PHARMACEUT TOULOUSE,PHARMACOL LAB,TOULOUSE,FRANCE
[3] CHU TOULOUSE,SERV PHARMACOL MED & CLIN,F-31073 TOULOUSE,FRANCE
[4] FAC MED TOULOUSE,F-31073 TOULOUSE,FRANCE
[5] FAC MED TOULOUSE,SERV BIOPHYS,F-31400 TOULOUSE,FRANCE
[6] LERS SYNTHELABO,DEPT CLIN RES,F-75013 PARIS,FRANCE
关键词
D O I
10.1111/j.1472-8206.1987.tb00546.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:67 / 75
页数:9
相关论文
共 18 条
[1]   SEMINAR ON CALCIUM CHANNEL BLOCKERS .1. INTRODUCTION - CALCIUM CHANNEL BLOCKERS [J].
BRAUNWALD, E .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (06) :1045-1046
[2]   REDUCTION OF ISCHEMIC DEPOLARIZATION BY THE CALCIUM-CHANNEL BLOCKER DILTIAZEM - CORRELATION WITH IMPROVEMENT OF VENTRICULAR CONDUCTION AND EARLY ARRHYTHMIAS IN THE DOG [J].
CLUSIN, WT ;
BUCHBINDER, M ;
ELLIS, AK ;
KERNOFF, RS ;
GIACOMINI, JC ;
HARRISON, DC .
CIRCULATION RESEARCH, 1984, 54 (01) :10-20
[3]  
GIESING D, 1982, CLIN PHARM, V1, P204
[5]  
GULKER H, 1984, EUR HEART J SUPPL, V5, P143
[6]  
HAINAUT F, 1984, THESIS PARIS 11
[7]   PHARMACOKINETICS OF DILTIAZEM AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
HERMANN, P ;
RODGER, SD ;
REMONES, G ;
THENOT, JP ;
LONDON, DR ;
MORSELLI, PL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (03) :349-352
[8]   THE PHARMACOKINETICS AND PHARMACOLOGY OF ORAL DILTIAZEM IN NORMAL VOLUNTEERS [J].
KINNEY, EL ;
MOSKOWITZ, RM ;
ZELIS, R .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :337-342
[9]  
KOHNO K, 1977, ARZNEIMITTEL-FORSCH, V27, P1424
[10]  
MORSELLI PL, 1979, 1978 DILT HAK S AMST, P151